Correlation Between Smith Nephew and DexCom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Smith Nephew and DexCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smith Nephew and DexCom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smith Nephew SNATS and DexCom Inc, you can compare the effects of market volatilities on Smith Nephew and DexCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smith Nephew with a short position of DexCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smith Nephew and DexCom.

Diversification Opportunities for Smith Nephew and DexCom

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Smith and DexCom is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and DexCom Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DexCom Inc and Smith Nephew is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smith Nephew SNATS are associated (or correlated) with DexCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DexCom Inc has no effect on the direction of Smith Nephew i.e., Smith Nephew and DexCom go up and down completely randomly.

Pair Corralation between Smith Nephew and DexCom

Considering the 90-day investment horizon Smith Nephew SNATS is expected to under-perform the DexCom. In addition to that, Smith Nephew is 1.03 times more volatile than DexCom Inc. It trades about -0.11 of its total potential returns per unit of risk. DexCom Inc is currently generating about 0.07 per unit of volatility. If you would invest  7,236  in DexCom Inc on September 2, 2024 and sell it today you would earn a total of  563.00  from holding DexCom Inc or generate 7.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Smith Nephew SNATS  vs.  DexCom Inc

 Performance 
       Timeline  
Smith Nephew SNATS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Smith Nephew SNATS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
DexCom Inc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Smith Nephew and DexCom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Smith Nephew and DexCom

The main advantage of trading using opposite Smith Nephew and DexCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smith Nephew position performs unexpectedly, DexCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will offset losses from the drop in DexCom's long position.
The idea behind Smith Nephew SNATS and DexCom Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios